NexgenRx Inc.
NXG.V
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 480.30K | 454.90K | 189.70K | -17.20K | -46.90K |
| Total Depreciation and Amortization | 215.00K | 232.70K | 171.80K | 184.80K | 199.80K |
| Total Amortization of Deferred Charges | 691.90K | 691.90K | 761.50K | 761.50K | 761.50K |
| Total Other Non-Cash Items | 289.60K | 291.50K | 47.50K | 51.90K | 51.20K |
| Change in Net Operating Assets | -441.50K | -1.07M | -451.30K | 169.60K | -76.20K |
| Cash from Operations | 1.24M | 599.30K | 719.40K | 1.15M | 889.50K |
| Capital Expenditure | -72.40K | -62.40K | -50.50K | -84.60K | -66.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -359.60K | -347.90K | -168.50K | -124.80K | -158.70K |
| Cash from Investing | -432.00K | -410.30K | -219.00K | -209.40K | -225.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -115.60K | -102.30K | -98.60K | -89.40K | -82.60K |
| Issuance of Common Stock | 62.50K | 187.50K | 187.50K | 187.50K | 187.50K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -403.30K | -404.80K | -639.70K | -640.10K | -667.70K |
| Other Financing Activities | 33.00K | 33.00K | 0.00 | 33.00K | -- |
| Cash from Financing | -416.90K | -317.30K | -573.70K | -542.60K | -589.60K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 386.60K | -128.30K | -73.50K | 398.50K | 74.60K |